Drug Information

Drug General Information
Drug ID
D0Y3UL
Former ID
DNC012539
Drug Name
3-(3,5-Dimethyl-phenyl)-piperidine
Drug Type
Small molecular drug
Indication Discovery agent Investigative [534764]
Formula
C13H19N
Canonical SMILES
CC1=CC(=CC(=C1)C2CCCNC2)C
InChI
1S/C13H19N/c1-10-6-11(2)8-13(7-10)12-4-3-5-14-9-12/h6-8,12,14H,3-5,9H2,1-2H3
InChIKey
KCTMOZHTZAFYSJ-UHFFFAOYSA-N
PubChem Compound ID
10035413
Target and Pathway
Target(s) D(2) dopamine receptor Target Info Inhibitor [534764]
KEGG Pathway Rap1 signaling pathway
cAMP signaling pathway
Neuroactive ligand-receptor interaction
Gap junction
Dopaminergic synapse
Parkinson's disease
Cocaine addiction
Alcoholism
PANTHER Pathway Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway
Dopamine receptor mediated signaling pathway
Nicotine pharmacodynamics pathway
Reactome Dopamine receptors
G alpha (i) signalling events
WikiPathways Hypothetical Network for Drug Addiction
Monoamine GPCRs
GPCRs, Class A Rhodopsin-like
Genes and (Common) Pathways Underlying Drug Addiction
GPCR ligand binding
GPCR downstream signaling
Nicotine Activity on Dopaminergic Neurons
References
Ref 534764J Med Chem. 1998 Dec 3;41(25):4933-8.N-n-Propyl-substituted 3-(dimethylphenyl)piperidines display novel discriminative properties between dopamine receptor subtypes: synthesis and receptor binding studies.
Ref 534764J Med Chem. 1998 Dec 3;41(25):4933-8.N-n-Propyl-substituted 3-(dimethylphenyl)piperidines display novel discriminative properties between dopamine receptor subtypes: synthesis and receptor binding studies.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.